Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


2 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 BMC Cancer
2 Cancer
20 Clin Infect Dis
1 HIV Med
6 J Acquir Immune Defic Syndr
17 J Infect Dis
3 J Virol
1 Lancet
3 Lancet Glob Health
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 Nat Med
1 PLoS Biol
12 PLoS One
2 PLoS Pathog
1 Science
3 Vaccine
3 Virology


  1. SANDERS EJ, Price MA, Karita E, Kamali A, et al
    Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001659.
    >> Share

  2. ROCHA C, Duarte J, Borrego P, Calado R, et al
    Potency of HIV-2-specific antibodies increase in direct association with loss of memory B-cells.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001661.
    >> Share

  3. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of On-Demand HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men Analysis of the ANRS IPERGAY study with a one-year follow-up.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001658.
    >> Share

  4. GOPALAPPA C, Sansom SL, Farnham PG, Chen YH, et al
    Combinations of interventions to achieve a national HIV incidence reduction goal: insights from the agent-based PATH 2.0 model.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001653.
    >> Share

  5. STAFFORD KA, Magder LS, Hungerford LL, Guralnik JM, et al
    Immunologic response to ART by age among treatment-naive patients in sub-Saharan Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001663.
    >> Share

  6. NISHIJIMA T, Mutoh Y, Kawasaki Y, Tomonari K, et al
    Cumulative exposure of tenofovir disoproxil fumarate is associated with kidney tubulopathy whether it is currently used or discontinued in HIV-infected patients.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001667.
    >> Share

  7. CREPAZ N, Tang T, Marks G, Hall HI, et al
    Changes in viral suppression status among HIV patients receiving care: United States, 2014.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001660.
    >> Share

  8. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    >> Share

  9. VICENZI E, Poli G
    Chronically infected T Cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001655.
    >> Share

  10. SABIN CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, et al
    Abacavir use and risk of recurrent myocardial infarction: the D: A: D Study.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001666.
    >> Share

  11. LEVINSON KL, Riedel DJ, Ojalvo LS, Chan W, et al
    Gynecologic cancer in HIV infected women: treatment and outcomes in a multi-institutional cohort.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001664.
    >> Share

    AIDS Res Hum Retroviruses

  12. SIMON L, Siggins R, Winsauer P, Brashear M, et al
    Simian immunodeficiency virus infection increases blood ethanol concentration duration after both acute and chronic administration.
    AIDS Res Hum Retroviruses. 2017 Oct 17. doi: 10.1089/AID.2017.0195.
    >> Share

  13. WANG YA, Nag M, Tuohy J, De Paris K, et al
    T regulatory cell induced Foxp3 binds the IL2, IFNgamma, and TNFalpha promoters in virus-specific CD8+ T cells from feline immunodeficiency virus infected cats.
    AIDS Res Hum Retroviruses. 2017 Oct 17. doi: 10.1089/AID.2017.0187.
    >> Share

    Antimicrob Agents Chemother

  14. ANDERSON PL, Liu AY, Castillo-Mancilla JR, Gardner EM, et al
    Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy: the DOT-DBS Study.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01710.
    >> Share

    BMC Cancer

  15. OBIRI-YEBOAH D, Akakpo PK, Mutocheluh M, Adjei-Danso E, et al
    Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    BMC Cancer. 2017;17:688.
    >> Share


  16. ROBERTS JM, Jin F, Poynten IM, Law C, et al
    Histological outcomes of anal high-grade cytopredictions.
    Cancer. 2017 Oct 20. doi: 10.1002/cncy.21936.
    >> Share

  17. GLEBER-NETTO FO, Zhao M, Trivedi S, Wang J, et al
    Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31063.
    >> Share

    Clin Infect Dis

  18. PASQUIER E, Kunda J, De Beaudrap P, Loyse A, et al
    Long term mortality and disability in Cryptococcal Meningitis: a systematic literature review.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

    Time to switch to second-line antiretroviral therapy in children with HIV in Europe and Thailand.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  20. THAO LTP, Heemskerk AD, Geskus RB, Mai NTH, et al
    Prognostic models for 9 month mortality in tuberculous meningitis.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  21. WAKE RM, Britz E, Sriruttan C, Rukasha I, et al
    High Cryptococcal Antigen Titers in Blood are Predictive of Subclinical Cryptococcal Meningitis Among HIV-Infected Patients.
    Clin Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  22. DIONNE-ODOM J, Geisler WM, Aaron KJ, Waites KB, et al
    High Prevalence of Multidrug-Resistant Mycoplasma genitalium in HIV-infected Men who have Sex with Men in Alabama.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  23. GEORGE IA, Spec A, Powderly WG, Santos CAQ, et al
    Comparative Epidemiology and Outcomes of HIV, Non-HIV Non-Transplant and Organ Transplant Associated Cryptococcosis: A Population-Based Study.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

  24. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  25. TAO G, Hoover KW, Nye MB, Peters PJ, et al
    Infrequent testing of women for rectal chlamydia and gonorrhea in the United States.
    Clin Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  26. SALAZAR-AUSTIN N, Hoffmann J, Cohn S, Mashabela F, et al
    Poor Obstetric and Infant Outcomes in HIV-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  27. BRAUN DL, Marzel A, Steffens D, Schreiber PW, et al
    High rates of subsequent asymptomatic STIs and risky sexual behavior in patients initially presenting with primary HIV-1 infection.
    Clin Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  28. NOSYK B, Min JE, Krebs E, Zang X, et al
    The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  29. SMIT M, van Zoest RA, Nichols BE, Vaartjes I, et al
    Cardiovascular disease prevention policy in HIV: recommendations from a modelling study.
    Clin Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  30. MEHTA SR, Chaillon A, Gaines TL, Gonzalez-Zuniga PE, et al
    Impact of Public Safety Policies on HIV Transmission Dynamics in Tijuana, Mexico.
    Clin Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  31. AKILIMALI NA, Chang CC, Muema DM, Reddy T, et al
    Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2017;65:1551-1559.
    >> Share

  32. OSMAN M, Lee K, Du Preez K, Dunbar R, et al
    Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa.
    Clin Infect Dis. 2017;65:1444-1452.
    >> Share

  33. WANG L, Min JE, Zang X, Sereda P, et al
    Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.
    Clin Infect Dis. 2017;65:1496-1503.
    >> Share

  34. PARR JB, Lodge EK, Holzmayer V, Pepin J, et al
    An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.
    Clin Infect Dis. 2017 Oct 18. doi: 10.1093.
    >> Share

  35. HO A, Aston SJ, Jary H, Mitchell T, et al
    Impact of HIV on the burden and severity of influenza illness in Malawian adults: a prospective cohort and parallel case-control study.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    >> Share

  36. BARBEE LA, Soge OO, Katz DA, Dombrowski JC, et al
    Increases in Neisseria gonorrhoeae with Reduced Susceptibility to Azithromycin among Men who have sex with Men (MSM), in Seattle, King County, Washington: 2012 - 2016.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    >> Share

  37. KENYON C
    Increases in asymptomatic early syphilis may be due to increases in repeat syphilis and not enhanced screening.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    >> Share

    HIV Med

  38. A note of thanks to referees for Volume 18, 2017.
    HIV Med. 2017;18:793-795.
    >> Share

    J Acquir Immune Defic Syndr

  39. VOJDEMAN FJ, Gaardbo JC, Hartling HJ, Gelpi M, et al
    CD52 expression on CD4+ T cells in HIV-positive individuals on cART.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001568.
    >> Share

  40. KOETHE JR, McDonnell W, Kennedy A, Abana CO, et al
    Adipose Tissue is Enriched for Activated and Late-differentiated CD8+ T cells, and Shows Distinct CD8+ Receptor Usage, Compared to Blood in HIV-infected Persons.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001573.
    >> Share

  41. TRAISATHIT P, Delory T, Ngo-Giang-Huong N, Somsamai R, et al
    AIDS-defining events and deaths in HIV-infected children and adolescents on antiretrovirals: a 14-year study in Thailand.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001571.
    >> Share

  42. KIDMAN R, Violari A
    Dating violence against HIV-infected youth in South Africa: Associations with sexual risk behavior, medication adherence, and mental health.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001569.
    >> Share

  43. HADDOW L, Laverick R, Leung I, Post F, et al
    Measurement of retinal vessels as a biomarker of cerebrovascular ageing in older HIV positive men compared to controls.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001570.
    >> Share

  44. NESHEIM SR, Linley L, Gray KM, Zhang T, et al
    Country of birth of children with diagnosed HIV infection in the United States, 2008-2014.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001572.
    >> Share

    J Infect Dis

  45. ROH ME, Shiboski S, Natureeba P, Kakuru A, et al
    Protective effect of indoor residual spraying of insecticide on preterm birth among pregnant women with HIV in Uganda: A secondary data analysis.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  46. MINIOR T, Douglas M, Edgil D, Srivastava M, et al
    The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

    Investigation of Human Immunodeficiency Virus Outbreaks Among People Who Inject Drugs: Timely Diagnosis and Molecular Surveillance are Crucial.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

    Implementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need?
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    >> Share

  49. CHUN HM, Obeng-Aduasare YF, Broyles LN, Ellenberger D, et al
    Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  50. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  51. CAMPBELL EM, Jia H, Shankar A, Hanson D, et al
    Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  52. ZHUKOVA A, Cutino-Moguel T, Gascuel O, Pillay D, et al
    The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  53. DONAHUE CARLSON R, Sheth AN, Read TD, Frisch MB, et al
    The Female Genital Tract Microbiome Is Associated With Vaginal Antiretroviral Drug Concentrations in Human Immunodeficiency Virus-Infected Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  54. SINGH D, Dhummakupt A, Siems L, Persaud D, et al
    Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  55. BORRE ED, Hyle EP, Paltiel AD, Neilan AM, et al
    The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    >> Share

  56. DUARTE HA, Panpradist N, Beck IA, Lutz B, et al
    Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  57. LI G, Nunoya JI, Cheng L, Reszka-Blanco N, et al
    Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4 T Cells Through cAMP-Dependent Mechanisms in Humanized Mice In Vivo.
    J Infect Dis. 2017 Oct 14. doi: 10.1093.
    >> Share

  58. SIBERRY GK, Amzel A, Ramos A, Rivadeneira ED, et al
    Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    >> Share

  59. BERTAGNOLIO S, Beanland RL, Jordan MR, Doherty M, et al
    The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  60. PINTYE J, Baeten JM, Celum C, Mugo N, et al
    Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    >> Share

  61. SILVERMAN RA, Beck IA, Kiptinness C, Levine M, et al
    Prevalence of Pre-antiretroviral Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-infected Individuals Initiating Therapy in Kenya, 2013-2014.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    >> Share

    J Virol

  62. YOUNG GR, Terry SN, Manganaro L, Cuesta-Dominguez A, et al
    HIV-1 infection of primary CD4+ T cells regulates the expression of specific HERV-K (HML-2) elements.
    J Virol. 2017 Oct 18. pii: JVI.01507-17. doi: 10.1128/JVI.01507.
    >> Share

  63. MWIMANZI F, Toyoda M, Mahiti M, Mann JK, et al
    Relative resistance of MHC-B to Nef-mediated downregulation is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals.
    J Virol. 2017 Oct 18. pii: JVI.01409-17. doi: 10.1128/JVI.01409.
    >> Share

  64. KASMAPOUR B, Kubsch T, Rand U, Eiz-Vesper B, et al
    Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors.
    J Virol. 2017 Oct 18. pii: JVI.01138-17. doi: 10.1128/JVI.01138.
    >> Share


    Adverse Outcomes of Reducing Foreign Aid for HIV Programs.
    JAMA. 2017;318:1431.
    >> Share

  66. FAUCI AS
    An HIV Vaccine is Essential for Ending the HIV/AIDS Pandemic.
    JAMA. 2017 Oct 9. doi: 10.1001/jama.2017.13505.
    >> Share


  67. IYER JK, Mendelson M
    Can the Antimicrobial Resistance Benchmark blaze a new trail?
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32670.
    >> Share

    Lancet Glob Health

  68. BADJE A, Moh R, Gabillard D, Guehi C, et al
    Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
    Lancet Glob Health. 2017;5:e1080-e1089.
    >> Share

  69. CHAISSON RE, Golub JE
    Preventing tuberculosis in people with HIV-no more excuses.
    Lancet Glob Health. 2017;5:e1048-e1049.
    >> Share

  70. GRUND JM, Bryant TS, Jackson I, Curran K, et al
    Association between male circumcision and women's biomedical health outcomes: a systematic review.
    Lancet Glob Health. 2017;5:e1113-e1122.
    >> Share

    MMWR Morb Mortal Wkly Rep

  71. STEIN R, Xu S, Marano M, Williams W, et al
    HIV Testing, Linkage to HIV Medical Care, and Interviews for Partner Services Among Women - 61 Health Department Jurisdictions, United States, Puerto Rico, and the U.S. Virgin Islands, 2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:1100-1104.
    >> Share

    N Engl J Med

  72. KENNEDY SB, Bolay F, Kieh M, Grandits G, et al
    Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
    N Engl J Med. 2017;377:1438-1447.
    >> Share

    Nat Med

  73. HUOT N, Jacquelin B, Garcia-Tellez T, Rascle P, et al
    Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys.
    Nat Med. 2017 Oct 16. doi: 10.1038/nm.4421.
    >> Share

    PLoS Biol

  74. RAZOOKY BS, Cao Y, Hansen MMK, Perelson AS, et al
    Nonlatching positive feedback enables robust bimodality by decoupling expression noise from the mean.
    PLoS Biol. 2017;15:e2000841.
    >> Share

    PLoS One

  75. JIANG X, Feyertag F, Robertson DL
    Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism.
    PLoS One. 2017;12:e0185790.
    >> Share

  76. MURRAY JM, Zaunders J, Emery S, Cooper DA, et al
    HIV dynamics linked to memory CD4+ T cell homeostasis.
    PLoS One. 2017;12:e0186101.
    >> Share

  77. UEMURA H, Tsukada K, Mizushima D, Aoki T, et al
    Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    PLoS One. 2017;12:e0186255.
    >> Share

  78. DAPP MJ, Kober KM, Chen L, Westfall DH, et al
    Patterns and rates of viral evolution in HIV-1 subtype B infected females and males.
    PLoS One. 2017;12:e0182443.
    >> Share

  79. FELDACKER C, Pintye J, Jacob S, Chung MH, et al
    Continuing professional development for medical, nursing, and midwifery cadres in Malawi, Tanzania and South Africa: A qualitative evaluation.
    PLoS One. 2017;12:e0186074.
    >> Share

  80. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    >> Share

  81. INAMBAO M, Kilembe W, Canary LA, Czaicki NL, et al
    Transitioning couple's voluntary HIV counseling and testing (CVCT) from stand-alone weekend services into routine antenatal and VCT services in government clinics in Zambia's two largest cities.
    PLoS One. 2017;12:e0185142.
    >> Share

  82. MWENGE L, Sande L, Mangenah C, Ahmed N, et al
    Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe.
    PLoS One. 2017;12:e0185740.
    >> Share

  83. DE VOEGHT A, Martens H, Renard C, Vaira D, et al
    Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium.
    PLoS One. 2017;12:e0185761.
    >> Share

  84. RAMOS DE SOUZA M, do Amaral WN, Alves Guimaraes R, Rezza G, et al
    Reproductive desire among women living with HIV/AIDS in Central Brazil: Prevalence and associated factors.
    PLoS One. 2017;12:e0186267.
    >> Share

  85. VAN LOO IHM, Dukers-Muijrers NHTM, Heuts R, van der Sande MAB, et al
    Screening for HIV, hepatitis B and syphilis on dried blood spots: A promising method to better reach hidden high-risk populations with self-collected sampling.
    PLoS One. 2017;12:e0186722.
    >> Share

  86. MULU A, Maier M, Liebert UG
    Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study.
    PLoS One. 2017;12:e0186619.
    >> Share

    PLoS Pathog

  87. PORTILLO JC, Muniz-Feliciano L, Lopez Corcino Y, Lee SJ, et al
    Toxoplasma gondii induces FAK-Src-STAT3 signaling during infection of host cells that prevents parasite targeting by autophagy.
    PLoS Pathog. 2017;13:e1006671.
    >> Share

  88. ROGANOWICZ MD, Komurlu S, Mukherjee S, Plewka J, et al
    TRIM5alpha SPRY/coiled-coil interactions optimize avid retroviral capsid recognition.
    PLoS Pathog. 2017;13:e1006686.
    >> Share


  89. WENDER PA, Hardman CT, Ho S, Jeffreys MS, et al
    Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
    Science. 2017;358:218-223.
    >> Share


  90. WU J, Zhao C, Liu Q, Huang W, et al
    Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31371.
    >> Share

  91. IZURIETA HS, Moro PL, Chen RT
    Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?
    Vaccine. 2017 Oct 12. pii: S0264-410X(17)31365.
    >> Share

  92. ANA-SOSA-BATIZ F, Johnston APR, Hogarth PM, Wines BD, et al
    Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31315.
    >> Share


  93. MA TC, Le Guo, Zhou RH, Wang X, et al
    Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Virology. 2017;513:91-97.
    >> Share

  94. DUFRASNE FE, Lucchetti M, Martin A, Andre E, et al
    Modulation of the NF-kappaB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism.
    Virology. 2017;513:11-16.
    >> Share

  95. YUE Y, Coskun AK, Jawanda N, Auer J, et al
    Differential interaction between human and murine Crm1 and lentiviral Rev proteins.
    Virology. 2017;513:1-10.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016